Showing results (351-360 of 411) with videos related to
Sort By:
Pageof 42
Cell Reports|September 28, 2023
Human NMDAR autoantibodies disrupt excitatory-inhibitory balance, leading to hippocampal network hypersynchronyMihai Ceanga, Vahid Rahmati, Holger Haselmann, et al.Brain : a Journal of Neurology|August 25, 2020
Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitisFrancesco Mannara, Marija Radosevic, Jesús Planagumà, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2009
SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survivalMaarten J Titulaer, Rinse Klooster, Marko Potman, et al.Clinical and Experimental Rheumatology|October 2, 2012
Classification and characterisation of peripheral neuropathies in 102 patients with primary Sjögren's syndromePilar Brito-Zerón, Miriam Akasbi, Xavier Bosch, et al.The Lancet. Neurology|February 16, 2024
Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort studyAmaia Muñoz-Lopetegi, Mar Guasp, Laia Prades, et al.Brain : a Journal of Neurology|March 1, 2024
HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 diseaseSelina M Yogeshwar, Sergio Muñiz-Castrillo, Lidia Sabater, et al.Neurology(R) Neuroimmunology & Neuroinflammation|January 28, 2021
Incidence and Impact of COVID-19 in MS: A Survey From a Barcelona MS UnitMaria Sepúlveda, Sara Llufriu, Eugenia Martínez-Hernández, et al.Neurology(R) Neuroimmunology & Neuroinflammation|March 7, 2015
Standardized test for anti-Tr/DNER in patients with paraneoplastic cerebellar degenerationChristian Probst, Lars Komorowski, Esther de Graaff, et al.Plos One|December 2, 2014
Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosisSara Llufriu, María Sepúlveda, Yolanda Blanco, et al.Pageof 42